glp 1 and intracranial hypertension Beyond weight loss: a case study narrative review of the potential role of glucagon-like peptide-1 receptor agonists for the treatment of idiopathic - Paulo The effect of glucagon-like peptide-1
Description
N Engl J Med 2025;392:20892099 [DOI] [PubMed] [Google Scholar] 157
M.ChungR
He takes metformin 1 g twice a day for his diabetes
It received US Food and Drug Administration (FDA) approval in 2014 for chronic weight management in adults with obesity or overweight and with at least one weight-related condition
